OrderlyMeds Tirzepatide Review: Cost, a Genuinely Visible Step-Up & Honest Verdict (2026)

OrderlyMeds publishes both its starter rate and its standing rate side by side, so the step-up is genuinely visible before you sign up — a rare level of pricing honesty among compounded telehealths. Every fact here comes from the company's own published program.

A genuinely visible price step-up

Worth highlighting directly: OrderlyMeds publishes the $74 semaglutide starter rate alongside its $149 standing rate — no hidden jump. The $74 figure is actually a two-month starter plan billed as $149 up front, open only to patients new to GLP-1 medication; the standing monthly rate afterward is also $149. Tirzepatide has no equivalent standing discount — $299/month is the ongoing rate from day one.

What OrderlyMeds is

OrderlyMeds is a telehealth provider, selling compounded semaglutide and tirzepatide with no membership fees or hidden costs, stated as such. It also offers brand-name routes priced openly at retail.

What OrderlyMeds costs

Tirzepatide runs a flat $299/month ongoing rate. Brand-name routes are priced at retail: Wegovy $1,839 and Zepbound $1,498. The dose ladder for semaglutide is published: four weeks at 0.25 mg then four weeks at 0.5 mg.

The brand-vs-compounded question

OrderlyMeds offers both compounded and brand-name routes, with the brand routes priced openly at full retail. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials; the brand option is the exact molecule and dose that was. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

OrderlyMeds's real strengths: both the starter and standing rates published together so the step-up is visible, no membership fees or hidden costs, a published dose ladder, and brand-name routes priced openly at retail. The trade-offs: the $74 starter is billed as $149 up front, is new-patient-only, and tirzepatide has no equivalent standing discount — $299/month applies from the start. As with any GLP-1 program, read the starter-plan billing terms closely before assuming $74 is your ongoing rate; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

OrderlyMeds's willingness to publish its starter and standing rates side by side is genuinely more honest than most competitors' "as low as" framing — you can see the real step-up before committing. Just note tirzepatide itself has no equivalent starter discount. For a provider with a flat rate that never escalates at all, compare it against CoreAge Rx or Ondra Health. For a provider whose advertised starter rate this review found is actually a three-month prepaid plan, see Ozari Health. See our best tirzepatide providers ranking for the full field.